COSTA MESA, Calif., Jan. 17, 2017 -- TTM Technologies, Inc. (NASDAQ:TTMI) will host a conference call on Wednesday, February 8th, at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time to discuss its fourth quarter 2016 performance.
Telephone access is available by dialing 888-278-8459 or international 913-312-1495 (ID 6391150). The conference call will also be simulcast on the company’s website, www.ttm.com, and will remain accessible for one week following the live event.
TTM Technologies will release its fourth quarter 2016 financial results after the market closes on Wednesday, February 8th, 2017.
About TTM
TTM Technologies, Inc. is a leading global printed circuit board manufacturer, focusing on quick-turn and technologically advanced PCBs, backplane assemblies and electro-mechanical solutions. TTM stands for time-to-market, representing how TTM's time-critical, one-stop manufacturing services enable customers to shorten the time required to develop new products and bring them to market. Additional information can be found at www.ttm.com.
Contact: Sameer Desai, Senior Director, Corporate Development & Investor Relations [email protected] 714-327-3050


U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Italy Fines Apple €98.6 Million Over App Store Dominance
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 



